Total Payments
$233,487
2024 Payments
$81,339
Companies
58
Transactions
1,120
Medicare Patients
6,324
Medicare Billing
$780,760
Payment Breakdown by Category
Other$178,466 (76.4%)
Food & Beverage$29,235 (12.5%)
Travel$21,867 (9.4%)
Consulting$3,810 (1.6%)
Education$108.16 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $173,066 | 87 | 74.1% |
| Food and Beverage | $29,235 | 953 | 12.5% |
| Travel and Lodging | $21,867 | 69 | 9.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $5,400 | 2 | 2.3% |
| Consulting Fee | $3,810 | 1 | 1.6% |
| Education | $108.16 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $94,323 | 275 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $51,351 | 75 | $0 (2024) |
| Allergan Inc. | $40,844 | 116 | $0 (2019) |
| NESTLE HEALTHCARE NUTRITION INC. | $18,348 | 34 | $0 (2023) |
| AIMMUNE THERAPEUTICS, INC. | $6,563 | 12 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $4,399 | 20 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,399 | 43 | $0 (2024) |
| Boston Scientific Corporation | $2,502 | 34 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,678 | 90 | $0 (2024) |
| Medtronic, Inc. | $1,629 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $81,339 | 245 | Phathom Pharmaceuticals, Inc. ($51,351) |
| 2023 | $14,588 | 196 | NESTLE HEALTHCARE NUTRITION INC. ($6,805) |
| 2022 | $20,299 | 150 | ABBVIE INC. ($13,983) |
| 2021 | $17,407 | 76 | AbbVie Inc. ($9,557) |
| 2020 | $9,229 | 47 | AbbVie Inc. ($7,706) |
| 2019 | $22,331 | 91 | Allergan Inc. ($13,610) |
| 2018 | $29,168 | 110 | AbbVie, Inc. ($14,809) |
| 2017 | $39,126 | 205 | AbbVie, Inc. ($16,991) |
All Payment Transactions
1,120 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Rare Disease | ||||||
| 12/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $77.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Boston Scientific Corporation | Axios (Device) | Food and Beverage | In-kind items and services | $137.85 | General |
| Category: Axios_ENDO | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Immunology | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Immunology | ||||||
| 11/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.22 | General |
| Category: GI | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Gastroenterology | ||||||
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Immunology | ||||||
| 11/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/08/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,812.50 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: LIVER DISEASE | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,583 | 1,706 | $875,448 | $193,522 |
| 2022 | 24 | 1,542 | 1,664 | $872,873 | $185,513 |
| 2021 | 26 | 1,574 | 1,688 | $895,781 | $197,728 |
| 2020 | 29 | 1,625 | 1,720 | $913,983 | $203,997 |
Total Patients
6,324
Total Services
6,778
Medicare Billing
$780,760
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 152 | 152 | $150,966 | $31,876 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 276 | 342 | $66,286 | $23,267 | 35.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 101 | 101 | $75,228 | $19,388 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 185 | $50,654 | $17,954 | 35.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 84 | 84 | $62,545 | $11,692 | 18.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 114 | 114 | $27,556 | $9,789 | 35.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 87 | 87 | $23,964 | $9,391 | 39.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 133 | 133 | $84,592 | $9,388 | 11.1% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 40 | $22,260 | $8,203 | 36.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 61 | 61 | $58,184 | $7,959 | 13.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 88 | 91 | $75,564 | $7,580 | 10.0% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 44 | 44 | $20,932 | $7,491 | 35.8% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 18 | 18 | $17,556 | $6,732 | 38.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 33 | 33 | $24,620 | $6,349 | 25.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 51 | 52 | $9,504 | $3,425 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $8,207 | $2,906 | 35.4% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 13 | 13 | $9,972 | $2,048 | 20.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 13 | 17 | $15,472 | $1,966 | 12.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 18 | 19 | $45,657 | $1,641 | 3.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 20 | $3,294 | $1,298 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $4,284 | $1,228 | 28.7% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 29 | 36 | $3,314 | $682.92 | 20.6% |
| 45330 | Diagnostic exam of lower portion of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $6,581 | $637.85 | 9.7% |
| 45331 | Biopsy of lower large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $8,256 | $631.59 | 7.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 136 | 136 | $137,376 | $28,937 | 21.1% |
About Dr. Niraj Jani, MD
Dr. Niraj Jani, MD is a Gastroenterology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386673671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niraj Jani, MD has received a total of $233,487 in payments from pharmaceutical and medical device companies, with $81,339 received in 2024. These payments were reported across 1,120 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($173,066).
As a Medicare-enrolled provider, Jani has provided services to 6,324 Medicare beneficiaries, totaling 6,778 services with total Medicare billing of $780,760. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Baltimore, MD
- Active Since 07/01/2006
- Last Updated 11/13/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1386673671
Products in Payments
- VOQUEZNA (Drug) $51,351
- CREON (Drug) $33,234
- LINZESS (Drug) $32,750
- ZENPEP (Drug) $31,987
- Creon (Drug) $14,442
- Humira (Biological) $7,329
- APRISO (Drug) $4,065
- UCERIS (Drug) $2,612
- VIBERZI (Drug) $1,342
- RINVOQ (Biological) $1,196
- STELARA (Biological) $1,190
- DUPIXENT (Biological) $1,157
- Axios (Device) $1,021
- XIFAXAN (Drug) $957.81
- XELJANZ (Drug) $894.34
- ENTYVIO (Biological) $871.71
- ZEPOSIA (Drug) $754.46
- ENDOFLIP (Device) $667.25
- SKYRIZI (Biological) $502.46
- HUMIRA (Biological) $448.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Baltimore
Sergey Kantsevoy, M.d., Ph.d, M.D., PH.D
Gastroenterology — Payments: $1.4M
Gastroenterology $1.4M
Aline Charabaty-Pishvaian
Gastroenterology — Payments: $903,660
Gastroenterology $903,660
Dr. Raymond Cross, Md, MD
Gastroenterology — Payments: $408,213
Gastroenterology $408,213
Paul Thuluvath, M.d, M.D
Gastroenterology — Payments: $404,660
Gastroenterology $404,660
Michael Goggins, M.d, M.D
Gastroenterology — Payments: $273,802
Gastroenterology $273,802
Aminur Khan, M.d, M.D
Gastroenterology — Payments: $143,871
Gastroenterology $143,871